| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2122942 | European Journal of Cancer | 2011 | 7 Pages |
Abstract
These data indicate that our induction regimen is feasible and well tolerated. A major response rate of 85% with 41% complete metastatic response confirms this regimen as effective induction in high-risk neuroblastoma.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Maria Antonietta De Ioris, Aurora Castellano, Ilaria Ilari, Maria Carmen Garganese, Gianluigi Natali, Alessandro Inserra, Rita De Vito, Lucilla Ravà , Maria Debora De Pasquale, Franco Locatelli, Alberto Donfrancesco, Alessandro Jenkner,